Physician profile
David B Friedman
NPI 1629141866
$2,964.36
in general payments reported to CMS, 2019-2025
18 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $229 · 2021: $146 · 2022: $241 · 2023: $858 · 2024: $778 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $633.76 | 2019-2024 | Otezla |
| Abbvie INC. | $564.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $355.40 | 2019-2025 | |
| Janssen Biotech, INC. | $238.53 | 2021-2024 | Tremfya, Simponi, Simponi Aria |
| Dermavant Sciences, INC. | $219.93 | 2024 | Vtama |
| Lilly USA, LLC | $178.50 | 2019-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $171.07 | 2023-2025 | Adbry, Anzupgo |
| Pfizer INC. | $170.64 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $88.74 | 2024-2025 | Camzyos, Eliquis |
| Fresenius Kabi USA, LLC | $79.53 | 2023 | Idacio |
| Genzyme Corporation | $56.25 | 2023 | |
| Incyte Corporation | $53.87 | 2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.52 | 2020-2024 | Duobrii, Siliq |
| Almirall LLC | $28.63 | 2025 | Klisyri |
| Celgene Corporation | $24.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $23.65 | 2020 | |
| Galderma Laboratories, L.P. | $20.77 | 2020 | |
| Organon LLC | $13.06 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.